Free Trial

Arbejdsmarkedets Tillaegspension Invests $24.27 Million in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Arbejdsmarkedets Tillaegspension disclosed a new stake in Amdocs, buying 301,477 shares valued at about $24.27 million and owning roughly 0.28% of the company.
  • Amdocs recently delivered a strong quarter, with Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both meeting or slightly beating analyst estimates.
  • Management also reaffirmed/raised fiscal 2026 guidance and pointed to a backlog increase to $4.28 billion, signaling continued demand and confidence in the company’s outlook.
  • MarketBeat previews the top five stocks to own by June 1st.

Arbejdsmarkedets Tillaegspension acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 301,477 shares of the technology company's stock, valued at approximately $24,272,000. Arbejdsmarkedets Tillaegspension owned approximately 0.28% of Amdocs as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alliancebernstein L.P. raised its holdings in shares of Amdocs by 32.1% during the third quarter. Alliancebernstein L.P. now owns 2,359,779 shares of the technology company's stock worth $193,620,000 after purchasing an additional 573,349 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Amdocs by 500.0% during the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 420,000 shares of the technology company's stock worth $34,461,000 after purchasing an additional 350,000 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Amdocs by 25.9% during the third quarter. AQR Capital Management LLC now owns 1,368,944 shares of the technology company's stock worth $111,309,000 after purchasing an additional 281,476 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Amdocs by 1,500.6% during the third quarter. Millennium Management LLC now owns 295,800 shares of the technology company's stock worth $24,270,000 after purchasing an additional 277,320 shares during the last quarter. Finally, LSV Asset Management raised its holdings in shares of Amdocs by 7.6% during the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company's stock worth $299,376,000 after purchasing an additional 257,193 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on DOX shares. Barclays cut their price objective on shares of Amdocs from $111.00 to $92.00 and set an "overweight" rating for the company in a report on Wednesday, February 4th. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, April 18th. Cfra cut shares of Amdocs to a "sell" rating in a report on Thursday. Stifel Nicolaus cut their price objective on shares of Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a report on Thursday. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Amdocs in a report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $86.67.

Check Out Our Latest Report on Amdocs

Key Headlines Impacting Amdocs

Here are the key news stories impacting Amdocs this week:

Amdocs Stock Performance

DOX opened at $61.93 on Friday. The firm has a market capitalization of $6.69 billion, a PE ratio of 12.39, a PEG ratio of 1.06 and a beta of 0.40. Amdocs Limited has a twelve month low of $59.40 and a twelve month high of $95.41. The firm's 50-day moving average price is $65.41 and its 200 day moving average price is $73.65. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The technology company reported $1.78 earnings per share for the quarter, topping analysts' consensus estimates of $1.77 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.67%. Amdocs's quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.78 earnings per share. Amdocs has set its FY 2026 guidance at 7.340-7.480 EPS and its Q3 2026 guidance at 1.810-1.870 EPS. As a group, sell-side analysts expect that Amdocs Limited will post 6.64 EPS for the current fiscal year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.569 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a yield of 3.7%. Amdocs's payout ratio is presently 44.10%.

Amdocs Profile

(Free Report)

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Recommended Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines